Clinical Data Featuring Device for Effectively Treating Cluster Headache Featured at 2016 Annual Meeting of American Headache Society
Therapeutic Response Demonstrated in 68% of Patients Suffering From Debilitating Headaches
Two-Year Study Results Show the Pulsante(R) Microstimulator Provides Sustained, long-Term Relief for Cluster Headache Patients
New Hope for Cluster Headache Sufferers
Two-Year Study Results Show the Pulsante(R) Microstimulator Provides Sustained, Long-Term Relief for Cluster Headache Patients
New Hope for Cluster Headache Sufferers
Autonomic Technologies Appoints Niamh Pellegrini as President and Chief Executive Officer
REDWOOD CITY, CA — (Marketwired) — 04/13/16 — Autonomic Technologies, Inc. (ATI) today announced the appointment of Niamh Pellegrini to the position of President and Chief Executive Officer and member of its board of directors. In this role, Ms. Pellegrini will lead the company–s efforts to bring innovative therapies to physicians and their patients who suffer from severe and disabling headaches.Ms. Pellegrini has over twenty-five years of experience in the healthcare industry including a b
Autonomic Technologies(R) Supports First Cluster Headache Day to Raise Awareness of This Debilitating Disease
MUNICH, GERMANY — (Marketwired) — 03/21/16 — Autonomic Technologies is a proud supporter of the first to raise awareness of this debilitating disease. March 21, the date of the spring equinox, has been declared by The European Headache Federation (EHF) and European Headache Alliance (EHA).Cluster headache affects up to 4 in 1,000 people. Despite being relatively unknown, it causes pain of such intensity and frequency that it is referred to as suicide headache. "More than 600,000 peopl
Autonomic Technologies(R) Supports First Cluster Headache Day to Raise Awareness of This Debilitating Disease
MUNICH, GERMANY — (Marketwired) — 03/21/16 — Autonomic Technologies is a proud supporter of the first to raise awareness of this debilitating disease. March 21, the date of the spring equinox, has been declared by The European Headache Federation (EHF) and European Headache Alliance (EHA).Cluster headache affects up to 4 in 1,000 people. Despite being relatively unknown, it causes pain of such intensity and frequency that it is referred to as suicide headache. "More than 600,000 peopl
Autonomic Technologies(R) Opens New International Headquarters to Further Drive Leadership in the Field of Neurostimulation in Headache
Pulsante(R) Microstimulator System Offers Cluster Headache Patients New Hope — Minimally-Invasive Treatment Now Available in Nine European Countries
Autonomic Technologies(R) Opens New International Headquarters to Further Drive Leadership in the Field of Neurostimulation in Headache
Pulsante(R) Microstimulator System Offers Cluster Headache Patients New Hope — Minimally-Invasive Treatment Now Available in Nine European Countries
Autonomic Technologies Completes Transatlantic Series D Financing of $43.2M
REDWOOD CITY, CA — (Marketwired) — 06/25/15 — Autonomic Technologies®, Inc. (ATI®), developer and manufacturer of Pulsante, a microstimulator to treat severe headaches, today announced the closing of its series D round of financing for an additional $5.5M from HBM Healthcare Investments LTD. This brings ATI–s round D funding to a total of $43.2M. The round was led by Edmond de Rothschild Investment Partners (EdRIP), the Paris based venture capital firm, syndicated with Forbion Capit
Autonomic Technologies(R) Announces 200 Cluster Headache Patients Implanted With the Pulsante(TM) Microstimulator
Pulsante Microstimulator — A New Frontier in Neuromodulation